Found 73 matches for
Department of Oncology researchers Dr Andrew Blackford and Dr Simon Lord have been appointed as Fellows of Oriel College.
8 April 2021
Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy despite lockdown.
17 February 2021
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
11 February 2021
Research Translational Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
9 October 2020
A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.
20 August 2020
Prof. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.
Artificial Intelligence Research Translational Research
22 July 2020
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
8 July 2020
Professor Nicola Sibson has been involved in the CNIO platform to compile a repository for brain metastasis cell lines.
General Outreach Research
4 June 2020
One of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.
Awards & Appointments Research
23 April 2020
Many congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).
26 March 2020
UK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical use.
9 March 2020
Group of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
Department Funding Research
6 February 2020
Congratulations to Prof Kristijan Ramadan who has been awarded a three year research grant from Breast Cancer Now. The grant will support Dr. Abhay Narayan Singh who will explore new ways to use chemotherapy in order to improve the outcomes for women with breast cancer.
Department Public Engagement Research
4 February 2020
Tuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/). Led by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.
Department Funding Research
4 November 2019
The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).
DNA Damage & Repair Publication Research
15 October 2019
Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
Department Immunology Research
20 September 2019
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Public Engagement Research
17 September 2019
On 14 September, the Old Road Campus joined the 2019 Oxford Open Doors event and welcomed the public into our workplace.
Clinical researchers at Oxford University announce new collaboration with Janssen to detect blood cancers sooner
Clinical Trials Research
8 August 2019
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
25 July 2019
Madalena Tarsounas' group have recently published two new papers in EMBO Molecular Medicine and Nature Communications.